PRTN3 and connective tissue disorder: For the evaluation of connective-tissue disease-associated ILD, markers such as RF, ACPA, anti-Scl-70 and anti-melanoma differentiation-associated gene 5 (MDA5), anti-tRNA synthetase antibodies are considered useful [28].